Plethora Solutions – Subscription of Shares

14 June 2012

Plethora Solutions Holdings PLC

("Plethora" or the "Company")

Subscription of Shares

Plethora Solutions Holdings plc (AIM: PLE), the UK-based speciality pharmaceutical company, announces that it has issued 7,000,000 new ordinary shares of 1p each to raise 350,000 issued at a price of 5p per share on a non pre-emptive basis in accordance with the authorities granted at the last general meeting (the "Subscription").

As part of the Subscription, Galloway Limited, a company owned by a trust in which Mr Jim Mellon, a non-executive director of Plethora, has a life interest, will subscribe for 5,000,000 new shares and as a result his indirect beneficial interest will increase to 25,000,000 new shares, being approximately 12.0% of the enlarged capital of the Company.

Application will be made for the new shares issued to be admitted to trading on AIM. ("Admission"). It is expected that Admission will be effective and trading will commence at 8:00am on 19 June 2012.

Jim Mellon said: "As a director I am delighted to assist in providing funds to drive the business forward. Now that the company has submitted its full dossier for approval by the European Medicines Agency of its treatment for premature ejaculation the company's future is particularly promising."

-Ends-

Enquiries:

Originally posted here:
Plethora Solutions - Subscription of Shares